Metro Inc.TSX: MRU

2026 Fourth Quarter Results PDF - 236 Kb

· Issued by Metro Inc.
INTERIM REPORT

12-week period ended September 26, 2026

4th Quarter 2026 and Fiscal 2026

HIGHLIGHTS

2026 FOURTH QUARTER

n Sales of $5,179.5 million, up 1.4%

n Food same-store sales(1) down 1.9%

n Pharmacy same-store sales(1) up 5.5%

n Net earnings of $201.9 million, down 7.0% and adjusted net earnings(1) of

$201.8 million, down 18.0%

n Fully diluted net earnings per share of $0.97, down 3.0% and adjusted fully diluted net earnings per share(1) of $0.97, down 14.2%

n Estimated lost profit and direct cost impact of the labour conflict at our produce distribution centre in Laval which ended on September 24, 2026 of $31 million after-tax or $0.16 per share (results are not adjusted for this impact)

n Returned $164.7 million to shareholders through share repurchases

n Opened four discount stores in the quarter including one conversion

FISCAL 2026

n Sales of $22,548.7 million, up 2.5%

n Net earnings of $886.1 million, down 13.1% and adjusted net earnings(1) of

$949.6 million, down 9.5%

n Fully diluted net earnings per share of $4.18, down 9.7% and adjusted fully diluted net earnings per share(1) of $4.48, down 6.1%

n Estimated lost profit and direct cost impact of the labour conflict at our produce distribution centre in Laval which ended on September 24, 2026 of $97 million after-tax or $0.48 per share (results are not adjusted for this impact)

n Opened 14 stores in the year including 13 discount stores of which 3 are conversions

(1) This measurement is presented for information purposes only. It does not have a standardized meaning prescribed by IFRS and therefore may not be comparable to similar measurements presented by other public companies. See table in section "Operating Results" and section on "Non-GAAP and Other Financial Measurements"

(2) See section on "Forward-looking Information"

‌Dear Shareholders,

We are presenting our interim report for the fourth quarter of Fiscal 2026 ended September 26, 2026.

Sales in the fourth quarter of Fiscal 2026 ended on September 26, 2026 were $5,179.5 million, up 1.4% versus the fourth quarter of the prior year which ended on September 27, 2025. Sales were positively impacted by new store openings, but were unfavorably impacted by the labour conflict at our produce distribution centre in Laval and its consequences on our food retail network in Quebec.

Food same-store sales(1) were down 1.9% in the fourth quarter of Fiscal 2026 (2025 - up 1.6%). Online food sales(1) were up 3.3% versus last year (2025 - 19.8%). Our food basket inflation was below the reported CPI of 2.4% for food purchased from stores. Pharmacy same-store sales(1) were up 5.5% (2025 - 4.8%), with a 6.5% increase in prescription drugs sales(1) and a 3.1% increase in front-store sales(1), primarily driven by over-the-counter products, cosmetics and seasonal products.

Fourth quarter net earnings were $201.9 million in Fiscal 2026 compared with $217.0 million for the corresponding quarter of 2025 and fully diluted net earnings per share were $0.97 compared with $1.00 in 2025, down 7.0% and 3.0% respectively. Net earnings were not adjusted for the labour conflict at our produce distribution centre in Laval which had an estimated unfavorable impact of $31 million after-tax or $0.16 per share.

Adjusted net earnings(1) for the fourth quarter of Fiscal 2026 totalled $201.8 million compared with $246.0 million for the corresponding quarter of 2025, and adjusted fully diluted net earnings per share(1) for the fourth quarter of Fiscal 2026 were $0.97, versus $1.13 in 2025, down 18.0% and 14.2% respectively. The fourth quarters of 2026 and 2025 included an adjustment for the after-tax amortization of intangible assets recorded in connection with the Jean Coutu Group acquisition. The fourth quarter of 2026 was also adjusted for a gain of $8.1 million after-tax related to the sale of Première Moisson Group Inc.'s commercial bakery manufacturing operations located in Baie-D'Urfé, and an impairment charge regarding related retail operations of $1.5 million after-tax. The fourth quarter of 2025 also included inventories write-down and other direct costs of $30.6 million, or $22.5 million net of the related taxes, related to the temporary shutdown of our frozen distribution centre in Toronto.

On September 28, 2026, the Board of Directors declared a quarterly dividend of $0.4075 per share, the same amount declared in the previous quarter.

Our fourth quarter results continued to be significantly impacted by the labour conflict at our produce distribution centre in Laval, which ended after six months on September 24. We have ramped up our operations and returned to normal service levels. Our focus is now on driving back customer traffic and volume to our stores.

We are pleased with the progress made on our strategic priorities. We continued the expansion of our discount network with 13 store openings during the year, including four in the quarter. The evolution of our e-commerce fulfillment model which started at the beginning of the quarter is in progress and should be completed by the end of the first quarter(2). On the pharmacy side, we are pleased with the continued momentum of our business which delivered strong same-store sales(1) growth in both prescription drugs and front-store sales(1).

I have strong confidence in our people, our banners and our strategy. While the economic environment remains challenging, METRO is well positioned to build on its strong foundation and continue creating sustainable long-term value for our customers, employees and shareholders(2).

Marc Giroux

President and Chief Executive Officer November 18, 2026

‌MANAGEMENT'S DISCUSSION AND ANALYSIS

The following Management's Discussion and Analysis (MD&A) sets out the financial position and consolidated results of METRO INC. (the Corporation) on September 26, 2026 for the 12-week period and fiscal year then ended. It should be read in conjunction with the unaudited interim condensed consolidated financial statements and accompanying notes in this interim report.

The unaudited interim condensed consolidated financial statements for the 12-week period and fiscal year ended September 26, 2026 have been prepared by management in accordance with IAS 34 Interim Financial Reporting. They should be read in conjunction with the audited annual consolidated financial statements and accompanying notes and the MD&A presented in the Corporation's 2025 Annual Report. Unless otherwise stated, the interim report is based on information as at November 6, 2026.

Additional information, including the Certification of Interim Filings for the fiscal year ended September 26, 2026 signed by the President and Chief Executive Officer and the Executive Vice President, Chief Financial Officer and Treasurer, will also be available in December on the SEDAR website at: https://www.sedarplus.ca.

‌OPERATING RESULTS SALES

Sales in the fourth quarter of Fiscal 2026 ended on September 26, 2026 were $5,179.5 million, up 1.4% versus the fourth quarter of the prior year which ended on September 27, 2025. Sales were positively impacted by new store openings, but were unfavorably impacted by the labour conflict at our produce distribution centre in Laval and its consequences on our food retail network in Quebec.

Food same-store sales(1) were down 1.9% in the fourth quarter of Fiscal 2026 (2025 - up 1.6%). Online food sales(1) were up 3.3% versus last year (2025 - 19.8%). Our food basket inflation was below the reported CPI of 2.4% for food purchased from stores. Pharmacy same-store sales(1) were up 5.5% (2025 - 4.8%), with a 6.5% increase in prescription drugs sales(1) and a 3.1% increase in front-store sales(1), primarily driven by over-the-counter products, cosmetics and seasonal products.

Sales for Fiscal 2026 totalled $22,548.7 million, up 2.5% compared to $22,006.7 million for Fiscal 2025.

OPERATING INCOME BEFORE DEPRECIATION AND AMORTIZATION, IMPAIRMENT OF ASSETS AND INVENTORIES WRITE-DOWN

This earnings measurement excludes financial costs, taxes, depreciation and amortization, impairment of assets and inventories write-down.

Gross margin(1) for the fourth quarter and Fiscal 2026 were 19.2% and 19.4% respectively versus 20.0% and 19.9% for the corresponding periods of 2025. Gross profit for the fourth quarter and Fiscal 2026 were unfavorably impacted by $40 million and $127 million respectively of estimated lost profit and incremental direct costs related to a labour conflict at our produce distribution centre in Laval.

Operating expenses as a percentage of sales for the fourth quarter of Fiscal 2026 were 10.7% versus 10.5% for the corresponding quarter of 2025. For Fiscal 2026, operating expenses as a percentage of sales were 10.5% versus 10.4% for Fiscal 2025. The fourth quarter and Fiscal 2026 included $2 million and $5 million respectively of incremental direct costs related to the labour conflict at our produce distribution centre in Laval.

Asset disposals in the fourth quarter of 2026 generated gains of $15.0 million, including $14.7 million related to the sale of Première Moisson Group Inc.'s commercial bakery manufacturing operations located in Baie-D'Urfé. In the fourth quarter of 2025, asset disposals generated losses of $1.9 million.

Operating income before depreciation and amortization, impairment of assets and inventories write-down for the fourth quarter of Fiscal 2026 totalled $454.2 million, or 8.8% of sales, a decrease of 6.3% versus the corresponding quarter of Fiscal 2025. Excluding the gain related to the sale of Première Moisson Group Inc.'s commercial bakery manufacturing operations, operating income before depreciation and amortization, impairment of assets and

inventories write-down as a percentage of sales would be 8.5%, a decrease of 10.4% from the prior year. Operating income before depreciation and amortization, impairment of assets and inventories write-down for Fiscal 2026 totalled

$2,001.1 million, or 8.9% of sales, down 3.9% versus Fiscal 2025. Management estimates that the labour conflict at our produce distribution centre in Laval negatively impacted the fourth quarter and Fiscal 2026 results by $42 million and $132 million respectively. This figure is based on estimated lost sales and associated estimated lost margins, realized inventory losses and incremental direct costs including third party logistics and security services.

DEPRECIATION AND AMORTIZATION

Total depreciation and amortization expense for the fourth quarter of Fiscal 2026 was $143.7 million versus

$139.8 million for the corresponding quarter of 2025. The increase in depreciation and amortization expense is mainly due to the increase in the retail network investments, including right-of-use assets, and technology investments. For Fiscal 2026, total depreciation and amortization expense was $625.2 million versus $594.4 million for Fiscal 2025.

IMPAIRMENT OF ASSETS

The Corporation recognized impairment of assets of $1.8 million during the fourth quarter of Fiscal 2026 regarding retail operations of the Première Moisson Group Inc. The impairment of assets related primarily to property and equipment, right-of-use assets, and leasehold improvements.

NET FINANCIAL COSTS

Net financial costs for the fourth quarter of Fiscal 2026 were $39.3 million compared with $34.4 million in the corresponding quarter of 2025. The increase in net financial costs is mainly due to higher interest expense on net debt. For Fiscal 2026, net financial costs were $164.4 million compared with $143.8 million for Fiscal 2025. The increase in net financial costs is mainly due to higher interest expense on net debt and to interest received in 2025 in connection with various tax matters.

INCOME TAXES

The income tax expense of $67.5 million for the fourth quarter of Fiscal 2026 represented an effective tax rate of 25.1% compared with an income tax expense of $69.0 million and an effective tax rate of 24.1% for the fourth quarter of Fiscal 2025.

The income tax expense of $291.5 million for Fiscal 2026 and $300.7 million for Fiscal 2025 represented effective tax rates of 24.8% and 22.8% respectively. The increase in the effective tax rate in 2026 is mainly attributable to a favourable $20.6 million income tax adjustment in respect of prior years in the first quarter of 2025. The provincial tax holiday on a large investment project was $23.6 million for Fiscal 2026 compared with $23.5 million for Fiscal 2025.

NET EARNINGS AND ADJUSTED NET EARNINGS(1)

Net earnings for the fourth quarter of Fiscal 2026 were $201.9 million compared with $217.0 million for the corresponding quarter of 2025, while fully diluted net earnings per share were $0.97 compared with $1.00 in 2025, down 7.0% and 3.0% respectively. Excluding the specific items shown in the table below, adjusted net earnings(1) for the fourth quarter of Fiscal 2026 totalled $201.8 million compared with $246.0 million for the corresponding quarter of 2025, and adjusted fully diluted net earnings per share(1) for the fourth quarter of Fiscal 2026 were $0.97, versus

$1.13 in 2025, down 18.0% and 14.2% respectively. Net earnings were not adjusted for the labour conflict at our produce distribution centre in Laval which had an estimated unfavorable impact of $31 million after-tax or $0.16 per share.

Net earnings for Fiscal 2026 were $886.1 million compared with $1,019.5 million for Fiscal 2025, while fully diluted net earnings per share were $4.18 compared with $4.63 in 2025, down 13.1% and 9.7% respectively. Excluding the specific items shown in the table below, adjusted net earnings(1) for Fiscal 2026 totalled $949.6 million compared with

$1,049.8 million for Fiscal 2025, and adjusted fully diluted net earnings per share(1) were $4.48 in 2026 versus $4.77 in 2025, down 9.5% and 6.1% respectively. Net earnings were not adjusted for the labour conflict at our produce distribution centre in Laval which had an estimated unfavorable impact of $97 million after-tax or $0.48 per share.

Net earnings and fully diluted net earnings per share (EPS) adjustments(1)

12 weeks / Fiscal Year

2026 2025 Change (%)

Net earnings (Millions of

dollars)

Fully diluted

EPS

(Dollars)

Net earnings (Millions of

dollars)

Fully diluted

EPS

(Dollars)

Net earnings

Fully diluted EPS

Per financial statements

Gain on disposal of commercial bakery

201.9

0.97

217.0

1.00

(7.0)

(3.0)

manufacturing assets and impairment of

related assets, net of tax of $6.0 (6.6) -

Inventories write-down and other direct costs due to the temporary frozen distribution

centre shutdown, net of taxes of $8.1 - 22.5

Amortization of intangible assets acquired in connection with the Jean Coutu Group

acquisition, net of taxes of $2.4

6.5

6.5

Adjusted measures(1)

201.8

0.97

246.0

1.13

(18.0)

(14.2)

52 weeks / Fiscal Year

2026 2025 Change (%)

Net earnings (Millions of

dollars)

Fully diluted

EPS

(Dollars)

Net earnings (Millions of

dollars)

Fully diluted

EPS

(Dollars)

Net earnings

Fully diluted EPS

Per financial statements

Gain on disposal of commercial bakery

886.1

4.18

1,019.5

4.63

(13.1)

(9.7)

manufacturing assets and impairment of

related assets, net of tax of $6.0 (6.6) -

Retail and distribution network restructuring

expenses, net of taxes of $6.8 18.9 -

Retail and distribution impairment of assets,

net of taxes of $8.4 23.7 -

Gain on the disposal of out-of-service

warehouses, net of taxes of $3.4 (16.7) -

Inventories write-down and other direct costs due to the temporary frozen distribution centre shutdown, net of taxes of $5.7 ($8.1

in 2025) 15.9 22.5

Amortization of intangible assets acquired in connection with the Jean Coutu Group

acquisition, net of taxes of $10.2 28.3 28.4

Favourable resolution of a tax position in

respect of prior years

-

(20.6)

Adjusted measures(1)

949.6

4.48

1,049.8

4.77

(9.5)

(6.1)

‌QUARTERLY HIGHLIGHTS

(Millions of dollars, unless otherwise indicated) 2026

2025

Change (%)

Sales

Q4(3) 5,179.5

5,108.7

1.4

Q3(4) 6,970.4

6,871.0

1.4

Q2(3) 5,113.0

4,909.9

4.1

Q1(3) 5,285.8

5,117.1

3.3

Net earnings

Q4(3) 201.9

217.0

(7.0)

Q3(4) 211.3

323.0

(34.6)

Q2(3) 246.6

220.0

12.1

Q1(3) 226.3

259.5

(12.8)

Adjusted net earnings(1)

Q4(3) 201.8

246.0

(18.0)

Q3(4) 262.6

331.8

(20.9)

Q2(3) 236.5

226.6

4.4

Q1(3) 248.7

245.4

1.3

Fully diluted net earnings per share (Dollars)

Q4(3) 0.97

1.00

(3.0)

Q3(4) 1.00

1.48

(32.4)

Q2(3) 1.16

0.99

17.2

Q1(3) 1.05

1.16

(9.5)

Adjusted fully diluted net earnings per share(1) (Dollars)

Q4(3) 0.97

1.13

(14.2)

Q3(4) 1.24

1.52

(18.4)

Q2(3) 1.11

1.02

8.8

Q1(3) 1.16

1.10

5.5

(3) 12 weeks

(4) 16 weeks

Sales in the fourth quarter of Fiscal 2026 ended on September 26, 2026 were $5,179.5 million, up 1.4% versus the fourth quarter of the prior year which ended on September 27, 2025. Sales were positively impacted by new store openings, but were unfavorably impacted by the labour conflict at our produce distribution centre in Laval and its consequences on our food retail network in Quebec. Food same-store sales(1) were down 1.9% in the fourth quarter of Fiscal 2026 (2025 - up 1.6%). Online food sales(1) were up 3.3% versus last year (2025 - 19.8%). Our food basket inflation was below the reported CPI of 2.4% for food purchased from stores. Pharmacy same-store sales(1) were up 5.5% (2025 - 4.8%), with a 6.5% increase in prescription drugs sales(1) and a 3.1% increase in front-store sales(1), primarily driven by over-the-counter products, cosmetics and seasonal products.

Sales in the third quarter of Fiscal 2026 ended on July 4, 2026 were $6,970.4 million, up 1.4% versus the third quarter of the prior year which ended on July 5, 2025. Sales were positively impacted by new store openings, but were unfavorably impacted by the ongoing labour conflict at our produce distribution centre in Laval and its consequences on our food retail network in Quebec. Food same-store sales(1) were down 1.5% in the third quarter of Fiscal 2026 (2025 - up 1.9%). Online food sales(1) were up 16.3% versus last year (2025 - 14.4%). Our food basket inflation was in line with the reported CPI of 3.9% for food purchased from stores. Pharmacy same-store sales(1) were up 4.8% (2025 - 5.5%), with a 6.4% increase in prescription drugs(1) and a 1.4% increase in front-store sales(1), primarily driven by cosmetics and health and beauty.

Sales in the second quarter of Fiscal 2026 ended on March 14, 2026 were $5,113.0 million, up 4.1% versus the second quarter of the prior year which ended on March 15, 2025. Sales were positively impacted by new store openings, same-store sales growth, as well as the transfer of one significant pre-Christmas shopping day to the second quarter this year. Food same-store sales(1) were up 1.8% in the second quarter of Fiscal 2026 (2025 - 5.3%) and up 1.5% when adjusting for the Christmas shift. Online food sales(1) were up 19.8% versus last year (2025 - 26.2%). Our food basket inflation was in line with the reported CPI of 4.3% for food purchased from stores. Pharmacy same-store sales(1) were up 5.1% (2025 - 7.0%), with a 6.1% increase in prescription drugs(1) and a 2.8% increase in front-store sales(1), primarily driven by cosmetics and health and beauty. When adjusting for the Christmas shift, front-store sales(1) were up 2.3%.

Sales in the first quarter of Fiscal 2026 ended on December 20, 2025 were $5,285.8 million, up 3.3% versus the first quarter of the prior year which ended on December 21, 2024. Sales were negatively impacted by the transfer of one significant pre-Christmas shopping day to the second quarter this year and by the temporary shutdown of our frozen food distribution centre in Toronto. Food same-store sales(1) were up 1.6% in the first quarter of Fiscal 2026 (2025 - 1.0%) and up 1.9% when adjusting for the Christmas shift. Online food sales(1) were up 25.8% versus last year (2025

- 18.6%). Our food basket inflation was below the reported CPI of 4.1% for food purchased from stores. Pharmacy same-store sales(1) were up 3.9% (2025 - 5.1%), with a 5.1% increase in prescription drugs(1) and a 1.3% increase in front-store sales(1), primarily driven by health and beauty and partially offset by a delayed cough and cold season. When adjusting for the Christmas shift, front-store sales(1) were up 1.7%.

Net earnings for the fourth quarter of Fiscal 2026 were $201.9 million compared with $217.0 million for the corresponding quarter of 2025, while fully diluted net earnings per share were $0.97 compared with $1.00 in 2025, down 7.0% and 3.0% respectively. Net earnings were not adjusted for the labour conflict at our produce distribution centre in Laval which had an estimated unfavorable impact of $31 million after-tax or $0.16 per share.

Adjusted net earnings(1) for the fourth quarter of Fiscal 2026 totalled $201.8 million compared with $246.0 million for the corresponding quarter of 2025, and adjusted fully diluted net earnings per share(1) for the fourth quarter of Fiscal 2026 were $0.97, versus $1.13 in 2025, down 18.0% and 14.2% respectively. The fourth quarters of 2026 and 2025 included an adjustment for the pre-tax amortization of intangible assets acquired in connection with the Jean Coutu Group acquisition of $8.9 million ($8.9 million in 2025), as well as the income taxes relating to this item. The fourth quarter of 2026 was also adjusted for a gain of $8.1 million after-tax related to the sale of Première Moisson Group Inc.'s commercial bakery manufacturing operations located in Baie-D'Urfé, and an impairment charge regarding related retail operations of $1.5 million after-tax. The fourth quarter of 2025 also included inventories write-down and other direct costs of $30.6 million, or $22.5 million net of the related taxes, related to the temporary shutdown of our frozen distribution centre in Toronto.

Net earnings for the third quarter of Fiscal 2026 were $211.3 million compared with $323.0 million for the corresponding quarter of 2025, while fully diluted net earnings per share were $1.00 compared with $1.48 in 2025, down 34.6% and 32.4% respectively. Net earnings were not adjusted for the labour conflict at our produce distribution centre in Laval which had an estimated unfavorable impact of $66 million after-tax or $0.32 per share.

Adjusted net earnings(1) for the third quarter of Fiscal 2026 totalled $262.6 million compared with $331.8 million for the corresponding quarter of 2025, and adjusted fully diluted net earnings per share(1) for the third quarter of Fiscal 2026 were $1.24, versus $1.52 in 2025, down 20.9% and 18.4% respectively. The third quarters of 2026 and 2025 included an adjustment for the pre-tax amortization of intangible assets acquired in connection with the Jean Coutu Group acquisition of $11.8 million ($11.9 million in 2025), as well as the income taxes relating to this item. The third quarter of 2026 was also adjusted for non-recurring restructuring expenses and impairment of assets totalling $42.6 million net of taxes or $0.20 per share, related to the optimization of our retail and distribution network. As part of our continued efforts to address our customers' ongoing search for value and to strengthen our competitive position in targeted markets, we are proceeding with a reorganization of our Ontario store and distribution network which will result in the conversion of 10 Metro stores to the Food Basics discount banner, the closure of one store and the closure of a satellite warehouse. In addition, we will close our dedicated e-commerce fulfillment centre in Montreal and leverage our store network for the expansion of our delivery offering while reducing our cost structure. This transition addresses evolving customer expectations for greater flexibility and immediacy in online grocery and supports the long-term profitability of our e-commerce operations. The restructuring is expected to be completed by the end of fiscal 2027 and generate an estimated $15 million of recurring annual net earnings by the end of Fiscal 2028(2).

Net earnings for the second quarter of Fiscal 2026 were $246.6 million compared with $220.0 million for the corresponding quarter of 2025, while fully diluted net earnings per share were $1.16 compared with $0.99 in 2025, up 12.1% and 17.2% respectively. Adjusted net earnings(1) for the second quarter of Fiscal 2026 totalled $236.5 million compared with $226.6 million for the corresponding quarter of 2025, and adjusted fully diluted net earnings per share(1) for the second quarter of Fiscal 2026 were $1.11, versus $1.02 in 2025, up 4.4% and 8.8% respectively. The second quarters of 2026 and 2025 included an adjustment for the pre-tax amortization of intangible assets acquired in connection with the Jean Coutu Group acquisition of $8.9 million, as well as the income taxes relating to this item. The second quarter of 2026 was also adjusted for a gain of $20.1 million, or $16.7 million net of taxes, related to the disposal of out-of-service warehouses.

Net earnings for the first quarter of Fiscal 2026 were $226.3 million compared with $259.5 million for the corresponding quarter of 2025, while fully diluted net earnings per share were $1.05 compared with $1.16 in 2025, down 12.8% and 9.5% respectively. Adjusted net earnings(1) for the first quarter of Fiscal 2026 totalled $248.7 million compared with $245.4 million for the corresponding quarter of 2025, and adjusted fully diluted net earnings per share(1) for the first quarter of Fiscal 2026 were $1.16, versus $1.10 in 2025, up 1.3% and 5.5% respectively. The first quarters of 2026 and 2025 included an adjustment for the pre-tax amortization of intangible assets acquired in connection with the Jean Coutu Group acquisition of $8.9 million, as well as the income taxes relating to this item. The first quarter of 2026 also included direct costs of $21.6 million, or $15.9 million net of taxes, related to the temporary shutdown of our frozen distribution centre in Toronto, while the first quarter of 2025 included a $20.6 million adjustment regarding the favourable resolution of an income tax position related to prior years.

2026 2025

(Millions of dollars) Q4 Q3 Q2 Q1 Q4 Q3 Q2 Q1

Net earnings

201.9

211.3

246.6

226.3

217.0

323.0

220.0

259.5

Gain on disposal of commercial bakery manufacturing assets and impairment of related assets, net of taxes

(6.6)

-

-

-

-

-

-

-

Retail and distribution network restructuring expenses, net of taxes

-

18.9

-

-

-

-

-

-

Retail and distribution impairment of assets, net of taxes

-

23.7

-

-

-

-

-

-

Gain on disposal of out-of-service warehouses, net of taxes

-

-

(16.7)

-

-

-

-

-

Inventories write-down and other direct costs due to the temporary frozen distribution centre shutdown, net of taxes

-

-

-

15.9

22.5

-

-

-

Amortization of intangible assets acquired in connection with the Jean Coutu Group acquisition, net of taxes

6.5

8.7

6.6

6.5

6.5

8.8

6.6

6.5

Favourable resolution of a tax position in respect of prior years

-

-

-

-

-

-

-

(20.6)

Adjusted net earnings(1)

201.8

262.6

236.5

248.7

246.0

331.8

226.6

245.4

2026 2025

(Dollars)

Q4

Q3

Q2

Q1

Q4

Q3

Q2

Q1

Fully diluted net earnings per share

0.97

1.00

1.16

1.05

1.00

1.48

0.99

1.16

Adjustments impact

-

0.24

(0.05)

0.11

0.13

0.04

0.03

(0.06)

Adjusted fully diluted net earnings per share(1)

0.97

1.24

1.11

1.16

1.13

1.52

1.02

1.10

‌CASH POSITION OPERATING ACTIVITIES

In the fourth quarter of Fiscal 2026, operating activities generated cash inflows of $436.4 million compared with

$499.1 million in the corresponding quarter of 2025. The decrease is mainly due to lower earnings in 2026 and to higher income taxes paid in 2026 due to timing.

For Fiscal 2026, operating activities generated cash inflows of $1,561.4 million compared with $1,724.9 million for Fiscal 2025. The decrease is mainly due to lower earnings in 2026 and to higher income taxes paid in 2026 compared to last year due to timing.

INVESTING ACTIVITIES

Investing activities required cash outflows of $48.3 million in the fourth quarter of Fiscal 2026 compared with

$183.2 million in the corresponding quarter of 2025. This difference stemmed mainly from lower investments in tangible and intangible assets of $47.9 million and net proceeds of $70.9 million from the 2026 disposal of the commercial bakery operations.

For Fiscal 2026, investing activities required cash outflows of $238.5 million compared with $408.6 million for Fiscal 2025. This difference stemmed mainly from lower investments in tangible and intangible assets of $54.0 million, and net proceeds from the disposal of commercial bakery operations and out-of-service warehouses in 2026 of $70.9 million and $37.5 million respectively.

During Fiscal 2026, we and our retailers opened or converted 14 stores, carried out major expansions and renovations of 11 stores, 2 stores were relocated and 1 store was closed, for a net increase of 359,000 square feet or 1.6% of our food retail network.

FINANCING ACTIVITIES

In the fourth quarter of 2026, financing activities required cash outflows of $327.9 million compared with

$324.2 million in the corresponding quarter of 2025. This difference is mainly due to lower share repurchases of

$113.2 million in the fourth quarter of 2026 offset by an increase in net debt of $115.0 million during the fourth quarter last year.

For Fiscal 2026, financing activities required cash outflows of $1,280.1 million compared with $1,278.4 million in 2025.

‌FINANCIAL POSITION

We do not anticipate(2) any liquidity risk and consider our financial position at the end of Fiscal 2026 as very solid. We had an unused authorized revolving credit facility of $600.0 million.

At the end of Fiscal 2026, the main elements of our debt were as follows:

Interest Rate Maturity

Rates fluctuate with changes in bankers'

Notional

(Millions of dollars)

Revolving Credit Facility

acceptance rates December 11, 2030 -

Series G Notes 3.39% fixed nominal rate December 6, 2027 450.0

Series L Notes 4.00% fixed nominal rate November 27, 2029 500.0

Series M Notes 3.47% fixed nominal rate February 25, 2031 350.0

Series K Notes 4.66% fixed nominal rate February 7, 2033 300.0

Series B Notes 5.97% fixed nominal rate October 15, 2035 400.0

Series D Notes 5.03% fixed nominal rate December 1, 2044 300.0

Series H Notes 4.27% fixed nominal rate December 4, 2047 450.0

Series I Notes 3.41% fixed nominal rate February 28, 2050 400.0

On February 25, 2026, the Corporation issued through a private placement Series M unsecured senior notes in the aggregate principal amount of $350.0 million, bearing interest at a fixed nominal rate of 3.469%, maturing on February 25, 2031.

On December 2, 2024, the Corporation redeemed all of the Series J notes, bearing interest at a fixed nominal rate of 1.92%, in the amount of $300.0 million that matured on the same day.

On November 27, 2024, the Corporation issued through a private placement Series L unsecured senior notes in the aggregate principal amount of $500.0 million, bearing interest at a fixed nominal rate of 3.998%, maturing on November 27, 2029. In anticipation of this issuance, on November 22, 2024, the Corporation entered into a bond forward contract designated as a cash flow hedge on a portion of a highly probable future debt issuance in the amount of $100.0 million that effectively locked in a 5-year fixed underlying Government of Canada yield of 3.351%. The effective part of the loss on the hedging instrument was recognized in Other Comprehensive Income. Following the Series L notes issuance, the amounts accumulated in equity will be reclassified to net financial costs on a linear basis over the life of the debt.

CAPITAL STOCK, STOCK OPTIONS AND PERFORMANCE SHARE UNITS

As at

September 26, 2026

As at

September 27, 2025

Number of Common Shares outstanding (Thousands)

207,465

214,748

Stock options:

Number outstanding (Thousands)

2,051

1,969

Exercise prices (Dollars)

55.94 to 102.08

47.51 to 102.08

Weighted average exercise price (Dollars)

73.75

69.65

Performance share units:

Number outstanding (Thousands) 516 551

NORMAL COURSE ISSUER BID PROGRAM

Under the current normal course issuer bid program, the Corporation may repurchase up to 10,000,000 of its Common Shares between November 27, 2025 and November 26, 2026. As at November 6, 2026, the Corporation has repurchased 6,800,000 Common Shares at an average price of $93.53, for a total consideration of $636.0 million. The Corporation intends(2) to renew its normal course issuer bid program as an additional option for using excess funds.

DIVIDENDS

On September 28, 2026, the Board of Directors declared a quarterly dividend of $0.4075 per share, the same amount declared in the previous quarter.

SHARE TRADING

The value of METRO shares remained in the $86.63 to $101.30 range over Fiscal 2026. During this period, a total of

139.6 million shares were traded on the Toronto Stock Exchange. The closing price on November 6, 2026 was $98.61 compared with $90.60 at the end of Fiscal 2026.

‌NEW ACCOUNTING STANDARD ACCOUNTING STANDARD ISSUED BUT NOT YET EFFECTIVE

Presentation and Disclosures in Financial Statements

In April 2024, the IASB issued IFRS 18, which replaces IAS 1 Presentation of Financial Statements, and consequential amendments to several other standards. IFRS 18 introduces new requirements for presentation within the statement of profit or loss, including specified totals and subtotals. Entities are required to classify all income and expenses within the statement of profit or loss into one of five categories: operating, investing, financing, income taxes and discontinued operations, with prescribed subtotals for each new category. It also requires disclosure of management-defined performance measures which will now form part of the audited financial statements.

IFRS 18, and the amendments to the other standards, is effective for reporting periods beginning on or after January 1, 2027, but earlier application is permitted and must be disclosed. IFRS 18 will apply retrospectively. The Corporation is currently working to identify all impacts the amendments will have on the consolidated financial statements and notes to the consolidated financial statements.

‌CONTINGENCIES

In the normal course of business, various proceedings and claims are instituted against the Corporation. The Corporation contests the validity of these claims and proceedings and at this stage, the Corporation does not believe(2) that these matters will have a material effect on the Corporation's financial position or on consolidated earnings. However, since any litigation involves uncertainty, it is not possible to predict the outcome of these claims or the amount of potential losses. No accruals or provisions for contingent losses have been recognized in the Corporation's annual consolidated financial statements.

In May 2019, two (2) proposed class actions relating to opioids were filed in Ontario and in Quebec by opioid end users against a large group of defendants including, in Quebec, a subsidiary of the Corporation, Pro Doc Ltée ("Pro Doc"), and, in Ontario, Pro Doc and The Jean Coutu Group (PJC) Inc. ("Jean Coutu Group"). In December 2023, the Ontario Superior Court of Justice dismissed the Ontario class action against Pro Doc, Jean Coutu Group and the distributor defendants. As plaintiff did not appeal the decision, this decision is therefore final. In April 2024, the Quebec Superior Court authorized the Québec class action, the authorization process being merely a procedural step and the judgment in no way decides the case on the merits. For the sole purpose of avoiding the costs and inconvenience of this class action, Pro Doc and its insurers have agreed to settle the Québec class action out of court, without any admission and while continuing to deny any allegation of fault or liability. The settlement agreement was approved by the Quebec Superior Court on December 22, 2025.

In August 2018, the Province of British Columbia filed a proposed class action against numerous manufacturers and distributors of opioids, including subsidiaries of the Corporation, Pro Doc and Jean Coutu Group. The Province of British Columbia seeks damages (unquantified) on behalf of all federal, provincial and territorial governments and agencies for expenses allegedly incurred in paying for opioid prescriptions and other healthcare costs that would be related to opioid addiction and abuse. In January 2025, the Court certified the class action against all defendants, the certification process being merely a procedural step and the judgment in no way decides the case on the merits. That decision was confirmed by the Court of Appeal in June 2026. For the sole purpose of avoiding the costs and inconvenience of this class action, Pro Doc, Jean Coutu Group and their insurers have agreed to an out-of-court settlement, without any admission and while continuing to deny any allegation of fault or liability. The settlement agreement has been submitted to the Supreme Court of British Columbia for approval. The Corporation does not expect(2) the settlement to have a material effect on its financial position, results of operations or cash flows.

In February 2020, a proposed class action relating to opioids was filed in British Columbia by opioid end users against a large group of defendants including subsidiaries of the Corporation, Pro Doc and Jean Coutu Group. In April 2021, a proposed class action relating to opioids was filed in Alberta by the City of Grande Prairie (Alberta) and the City of Brantford (Ontario). That proposed class action, amended in late November 2024, is made against multiple defendants, including the Corporation, Pro Doc and Jean Coutu Group. In September 2021, a proposed class action relating to opioids was filed by the Peter Ballantyne Cree Nation and the Lac La Ronge Indian Band, in Saskatchewan. That proposed class action, amended in May 2026, was brought against multiple defendants, including the Corporation, Pro Doc and Jean Coutu Group. The allegations in these proposed class actions are similar to the allegations contained in the proposed class action filed by the Province of British Columbia in 2018. They include allegations of breach of the Competition Act, of fraudulent misrepresentation and deceit, and negligence. The City of Grande Prairie, on its behalf and on behalf of all Canadian municipalities and local governments, seeks damages which are unquantified in relation to public safety, social service, and criminal justice costs allegedly incurred due to the opioid crisis. The Peter Ballantyne Cree Nation and the Lac La Ronge Indian Band are attempting a similar recourse, claiming unquantified damages from multiple defendants on their own behalf and on behalf of all Indigenous, First Nations, Inuit and Metis communities and governments in Canada. The Corporation believes(2) these proceedings are without merits and that, in certain cases, there is no jurisdiction. No provisions for contingent losses have been recognized in the Corporation's annual financial statements.

In 2017, the Canadian Competition Bureau began an investigation into the supply and sale of commercial bread which involves certain Canadian suppliers and retailers, including the Corporation. Based on the information available to date, the Corporation does not believe that it or any of its employees have violated the Competition Act. Proposed class-action lawsuits have also been filed against the Corporation, suppliers and other retailers. On December 19, 2019, the Quebec Superior Court granted the application for authorization to institute one of these class actions, the authorization process being merely a procedural step and the judgment in no way decides the case on the merits. On December 31, 2021, the Ontario Superior Court of Justice partially certified another of these class actions. The Corporation is contesting all these actions at the certification stage and on the merits. No provisions for contingent losses have been recognized in the Corporation's annual consolidated financial statements.

During the 2016 fiscal year, an application for authorization to institute a class action was served on Jean Coutu Group by Sopropharm, an association incorporated under the Professional Syndicates Act of which certain franchised drugstore owners of the Jean Coutu Group are members. The application seeks to have the class action authorized in the form of a declaratory action seeking amongst others (i) to set aside certain contractual provisions of the Jean Coutu Group's standard franchise agreements, including the clause providing for the payment of royalties on sales of medication by franchised establishments; (ii) to restore certain benefits; and (iii) to reduce certain contractual obligations. On November 1, 2018, the Quebec Superior Court granted the application for authorization to institute a class action, the authorization process being merely a procedural step and the judgment in no way decides the case on the merits. The Corporation contests this action on the merits. No provisions for contingent losses have been recognized in the Corporation's annual consolidated financial statements.

‌FORWARD-LOOKING INFORMATION

We have used, throughout this report, different statements that could, within the context of regulations issued by the Canadian Securities Administrators, be construed as being forward-looking information. In general, any statement contained herein that does not constitute a historical fact may be deemed a forward-looking statement. Expressions such as "anticipate", "believe", "expect", "should", "continue", "intend" and other similar expressions are generally indicative of forward-looking statements. The forward-looking statements contained herein are based upon certain assumptions regarding the Canadian food and pharmaceutical industries, the general economy, our annual budget, as well as our 2027 action plan.

These forward-looking statements do not provide any guarantees as to the future performance of the Corporation and are subject to potential risks, known and unknown, as well as uncertainties that could cause the outcome to differ significantly. Risk factors that could cause actual results or events to differ materially from our expectations as expressed in, or implied by, our forward-looking statements are described and discussed under the "Risk Management" section in our Annual Report 2025.

We believe these statements to be reasonable and pertinent as at the date of publication of this report and represent our expectations. The Corporation does not intend to update any forward-looking statement contained herein, except as required by applicable law.

‌NON-GAAP AND OTHER FINANCIAL MEASUREMENTS

In addition to the International Financial Reporting Standards (IFRS) measurements provided, we have included certain non-GAAP and other financial measurements. These measurements are presented for information purposes only. They do not have a standardized meaning prescribed by IFRS and therefore may not be comparable to similar measurements presented by other public companies.

National Instrument 52-112 Non-GAAP and Other Financial Measures Disclosure sets out specific disclosure requirements for non-GAAP financial measures, non-GAAP ratios, and other financial measures, which are capital management measures, supplementary financial measures, and total of segments measures, as defined in the Instrument (together the "specified financial measures").

The specified financial measures we disclose in our documents made available to the public are presented by measurement categories below.

NON-GAAP FINANCIAL MEASURES

Adjusted earnings before net financial costs and income taxes is a non-GAAP financial measurement that, with respect to its composition, is adjusted to exclude net financial costs and special items from the composition of the most directly comparable financial measure disclosed in our consolidated financial statements, which is earnings before income taxes. Special items may include acquisition and restructuring charges, gains or losses on the disposal of investments, and amortization and impairment losses of intangible assets resulting from a business acquisition.

Adjusted net earnings is a non-GAAP financial measurement that, with respect to its composition, is adjusted to exclude special items from the composition of the most directly comparable financial measure disclosed in our consolidated financial statements, which is net earnings. Special items may include acquisition and restructuring charges, gains or losses on the disposal of investments, amortization and impairment losses of intangible assets resulting from a business acquisition, and significant prior-year tax adjustments.

For measurements depicting financial performance, we believe that presenting earnings adjusted for these items, which are not necessarily reflective of the Corporation's performance, leaves readers of financial statements better informed thus enabling them to better perform trend analysis, evaluate the Corporation's financial performance and assess its future outlook. Adjusting for these items does not imply that they are non-recurring.

NON-GAAP RATIOS

Adjusted fully diluted net earnings per share is a non-GAAP ratio in which a non-GAAP financial measure is used as one or more of its components. The non-GAAP component used is adjusted net earnings(1). Adjusted fully diluted net earnings per share is calculated by dividing the adjusted net earnings(1) attributable to equity holders of the parent by the weighted average number of Common Shares outstanding during the year, adjusted to reflect all potential dilutive shares.

We believe that presenting this ratio, in which a non-GAAP financial measurement is used as one or more of its components, leaves readers of financial statements better informed as to the current period and corresponding prior year's period's performance, thus enabling them to better perform trend analysis, evaluate the Corporation's financial performance and assess its future outlook. Adjusting for these items does not imply that they are non-recurring.

SUPPLEMENTARY FINANCIAL MEASURES

The supplementary financial measures listed below are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Corporation.

Food same-store sales are defined as comparable retail sales of stores with more than 52 consecutive weeks of operations, including relocated, expanded and renovated locations. Food same-store sales is a measure based on all stores in our network, including those whose sales are not included in the Corporation's consolidated financial statements.

Online food sales are the sum of sales made from all our online channels.

Pharmacy same-store sales (including total, front-store and prescription drugs) are defined as comparable retail sales of stores with more than 52 consecutive weeks of operations, including relocated, expanded and renovated locations. Pharmacy same-store sales do not form part of the Corporation's consolidated financial statements because the pharmacies are held by pharmacist owners.

Gross margin ratio is calculated by dividing gross profit by sales.

‌OUTLOOK(2)

The labour conflict at our produce distribution centre in Laval ended on September 24, 2026, and we have ramped up our operations and returned to normal service levels. Our focus is now on driving back customer traffic and volume to our stores and after four weeks in the first quarter, our food same store sales(1) remain negative but have started to improve.

As we enter Fiscal 2027, we continue to advance the expansion of our discount store network. Following the announcement of our Ontario store network restructuring in the third quarter, we completed the first of 10 planned Metro-to-Food Basics conversions in the fourth quarter, with the remaining nine planned for this year. Combined with seven new discount store openings planned for Fiscal 2027, these initiatives will expand our discount footprint and strengthen our ability to meet evolving customer trends. On the pharmacy side, we are very well positioned for growth including capturing the opportunity related to the upcoming expansion in the scope of practice of pharmacists in Québec.

Despite the near-term macro-economic challenges, we remain confident in the strength of our food and pharmacy businesses and our competitive positioning. We are steadfast in our efforts to deliver compelling value to our customers through effective merchandising programs, strong private labels, our Moi program and consistent execution at store level. With a disciplined focus on execution and on our strategic priorities, we are well positioned to continue creating long-term value for our shareholders.

Montréal, November 18, 2026

‌Interim Condensed Consolidated Financial Statements (Unaudited)

METRO INC.

September 26, 2026

Table of contents

‌Page

Consolidated statements of net income................................................................................................................... 17

Consolidated statements of comprehensive income.............................................................................................. 18

Consolidated statements of financial position......................................................................................................... 19

Consolidated statements of changes in equity........................................................................................................ 20

Consolidated statements of cash flows.................................................................................................................... 21

Notes to interim condensed consolidated financial statements............................................................................ 22

  1. Statement presentation ........................................................................................................................................ 22

  2. New accounting standard .................................................................................................................................... 22

  3. Sales........................................................................................................................................................................ 22

  4. Restructuring expenses and impairment of assets.......................................................................................... 23

  5. Disposal of commercial bakery operations ....................................................................................................... 23

  6. Inventories write-down.......................................................................................................................................... 24

  7. Income taxes.......................................................................................................................................................... 24

  8. Net earnings per share......................................................................................................................................... 24

  9. Debt ......................................................................................................................................................................... 25

  10. Capital stock ........................................................................................................................................................ 25

  11. Contingencies ...................................................................................................................................................... 27

  12. Financial instruments.......................................................................................................................................... 28

  13. Changes in defined benefit plans..................................................................................................................... 29

  14. Comparative figures............................................................................................................................................ 29

  15. Approval of financial statements....................................................................................................................... 29

Consolidated statements of net income

Periods ended September 26, 2026 and September 27, 2025

(Unaudited) (Millions of dollars, except for net earnings per share)

‌12 weeks 52 weeks‌

Fiscal Year Fiscal Year

2026

2025

2026

2025

Sales (note 3)

5,179.5

5,108.7

22,548.7

22,006.7

Cost of sales

(4,185.7)

(4,086.9)

(18,177.8)

(17,636.4)

Gross profit

993.8

1,021.8

4,370.9

4,370.3

Operating expenses

(554.6)

(535.2)

(2,376.2)

(2,287.5)

Restructuring expenses (note 4)

-

-

(25.7)

-

Net gains (losses) on disposal of assets (note 5)

15.0

(1.9)

32.1

0.1

Operating income before depreciation and amortization, impairment of assets and inventories write-down

454.2

484.7

2,001.1

2,082.9

Depreciation and amortization

(143.7)

(139.8)

(625.2)

(594.4)

Impairment of assets (note 4)

(1.8)

-

(33.9)

-

Inventories write-down (note 6)

-

(24.5)

-

(24.5)

Net financial costs

(39.3)

(34.4)

(164.4)

(143.8)

Earnings before income taxes

269.4

286.0

1,177.6

1,320.2

Income taxes (note 7)

(67.5)

(69.0)

(291.5)

(300.7)

Net earnings

201.9

217.0

886.1

1,019.5

Attributable to:

Equity holders of the parent

200.8

216.0

883.9

1,017.0

Non-controlling interest

1.1

1.0

2.2

2.5

201.9

217.0

886.1

1,019.5

Net earnings per share (Dollars) (note 8)

Basic

0.96

1.01

4.19

4.65

Fully diluted

0.97

1.00

4.18

4.63

See accompanying notes

(Unaudited) (Millions of dollars)

‌12 weeks 52 weeks‌

Fiscal Year Fiscal Year

2026

2025

2026

2025

Net earnings

201.9

217.0

886.1

1,019.5

Other comprehensive income

Items that will not be reclassified to net earnings Changes in defined benefit plans

Actuarial gains (losses) (note 13)

(15.4)

58.6

37.4

128.3

Asset ceiling effect

(31.4)

(3.7)

(37.4)

(9.2)

Corresponding income taxes 12.4

(14.6)

-

(31.6)

(34.4)

40.3

-

87.5

Items that will be reclassified later to net earnings

Change in fair value of derivatives designated as cash flow hedges

-

-

-

(0.7)

Reclassification of the change in fair value of derivatives designated as cash flow hedges to net earnings

-

0.1

0.3

0.3

Corresponding income taxes

-

-

(0.1)

0.1

-

0.1

0.2

(0.3)

(34.4)

40.4

0.2

87.2

Comprehensive income

167.5

257.4

886.3

1,106.7

Attributable to:

Equity holders of the parent

166.4

256.4

884.1

1,104.2

Non-controlling interest

1.1

1.0

2.2

2.5

167.5

257.4

886.3

1,106.7

See accompanying notes

(Unaudited) (Millions of dollars)

‌As at‌

As at

September 26, 2026

September 27, 2025

ASSETS

Current assets

Cash and cash equivalents

110.1

67.3

Accounts receivable (note 14)

826.4

774.2

Accounts receivable on subleases

98.3

91.9

Inventories

1,617.6

1,604.3

Prepaid expenses (note 14)

118.9

79.4

Current taxes

61.4

43.9

Non-current assets

2,832.7

2,661.0

Fixed assets

4,038.2

4,063.0

Right-of-use assets

1,160.0

1,022.6

Intangible assets

2,624.8

2,661.2

Goodwill

3,299.0

3,317.1

Deferred taxes

32.8

34.2

Defined benefit assets

275.4

310.2

Accounts receivable on subleases

370.9

376.2

Other assets

97.7

93.9

14,731.5

14,539.4

LIABILITIES AND EQUITY

Current liabilities

Accounts payable

1,666.2

1,661.8

Deferred revenues

38.3

44.6

Current taxes

33.6

54.3

Current portion of debt (note 9)

17.4

17.2

Current portion of lease liabilities

290.5

275.9

Non-current liabilities

2,046.0

2,053.8

Debt (note 9)

3,169.3

2,938.1

Lease liabilities

1,497.4

1,370.8

Defined benefit liabilities

36.5

38.3

Deferred taxes

1,069.5

1,088.9

Other liabilities

16.0

4.4

7,834.7

7,494.3

Equity

Attributable to equity holders of the parent

6,877.8

7,026.7

Attributable to non-controlling interest

19.0

18.4

6,896.8

7,045.1

14,731.5

14,539.4

See accompanying notes

‌Attributable to the equity holders of the parent‌

Accumulated

Capital stock

Treasury shares

Contributed

Retained

other comprehensive

Non-controlling

Total

(note 10)

(note 10)

surplus

earnings

income

Total

interest

equity

Balance as at September 27, 2025

1,544.7

(25.1)

26.9

5,481.6

(1.4)

7,026.7

18.4

7,045.1

Net earnings

-

-

-

883.9

-

883.9

2.2

886.1

Other comprehensive income

-

-

-

-

0.2

0.2

-

0.2

Comprehensive income

-

-

-

883.9

0.2

884.1

2.2

886.3

Stock options exercised

8.1

-

(1.0)

-

-

7.1

-

7.1

Shares redeemed (note 10)

(53.6)

-

-

-

-

(53.6)

-

(53.6)

Share redemption premium (note 10)

-

-

-

(642.9)

-

(642.9)

-

(642.9)

Tax on share redemption

-

-

-

(13.8)

-

(13.8)

-

(13.8)

Acquisition of treasury shares

-

(5.8)

-

-

-

(5.8)

-

(5.8)

Share-based compensation cost

-

-

10.3

-

-

10.3

-

10.3

Performance share units settlement

-

7.2

(5.7)

(0.1)

-

1.4

-

1.4

Dividends

-

-

-

(335.7)

-

(335.7)

(0.9)

(336.6)

Buyout of minority interests

-

-

-

-

-

-

(0.7)

(0.7)

(45.5)

1.4

3.6

(992.5)

-

(1,033.0)

(1.6)

(1,034.6)

Balance as at September 26, 2026

1,499.2

(23.7)

30.5

5,373.0

(1.2)

6,877.8

19.0

6,896.8

Attributable to the equity holders of the parent

Accumulated

Capital stock (note 10)

Treasury shares (note 10)

Contributed

surplus

Retained earnings

other comprehensive

income Total

Non-controlling interest

Total equity

Balance as at September 28, 2024

1,575.5

(19.6)

25.5

5,441.4

(1.1)

7,021.7

17.2

7,038.9

Net earnings

-

-

-

1,017.0

-

1,017.0

2.5

1,019.5

Other comprehensive income

-

-

-

87.5

(0.3)

87.2

-

87.2

Comprehensive income

-

-

-

1,104.5

(0.3)

1,104.2

2.5

1,106.7

Stock options exercised

27.4

-

(3.3)

-

-

24.1

-

24.1

Shares redeemed (note 10)

(58.2)

-

-

-

-

(58.2)

-

(58.2)

Share redemption premium (note 10)

-

-

-

(731.8)

-

(731.8)

-

(731.8)

Tax on share redemption

-

-

-

(15.7)

-

(15.7)

-

(15.7)

Acquisition of treasury shares

-

(11.3)

-

-

-

(11.3)

-

(11.3)

Share-based compensation cost

-

-

9.9

-

-

9.9

-

9.9

Performance share units settlement

-

5.8

(5.2)

-

-

0.6

-

0.6

Dividends

-

-

-

(316.8)

-

(316.8)

(0.3)

(317.1)

Buyout of minority interests

-

-

-

-

-

-

(1.0)

(1.0)

(30.8)

(5.5)

1.4

(1,064.3)

-

(1,099.2)

(1.3)

(1,100.5)

Balance as at September 27, 2025

1,544.7

(25.1)

26.9

5,481.6

(1.4)

7,026.7

18.4

7,045.1

See accompanying notes

‌12 weeks 52 weeks‌

Fiscal Year Fiscal Year

2026

2025

2026

2025

Operating activities

Earnings before income taxes

269.4

286.0

1,177.6

1,320.2

Non-cash items

Depreciation and amortization

143.7

139.8

625.2

594.4

Restructuring expenses (note 4)

-

-

25.7

-

Net (gains) losses on disposal of assets (note 5)

(15.0)

1.9

(32.1)

(0.1)

Impairment of assets (note 4)

1.8

-

33.9

-

Inventories write-down (note 6)

-

24.5

-

24.5

Share-based compensation cost

3.3

3.3

14.3

13.8

Difference between amounts paid for employee benefits and

current period cost

9.0

10.7

44.1

43.0

Net financial costs

39.3

34.4

164.4

143.8

451.5

500.6

2,053.1

2,139.6

Net change in non-cash working capital items

68.0

53.8

(130.1)

(126.7)

Income taxes paid

(83.1)

(55.3)

(361.6)

(288.0)

436.4

499.1

1,561.4

1,724.9

Investing activities

Net proceeds on disposal of commercial bakery operations (note 5)

70.9

-

70.9

-

Buyout of minority interests

-

-

(0.7)

(1.0)

Net change in other assets

1.9

(11.5)

(7.4)

(13.6)

Additions to fixed assets

(126.8)

(171.9)

(394.6)

(452.5)

Disposals of fixed assets

3.6

0.5

41.6

5.6

Additions to intangible assets and goodwill

(15.3)

(18.1)

(62.0)

(58.1)

Payments received from subleases

15.2

15.3

99.9

95.6

Interest received from subleases

2.2

2.5

13.8

15.4

(48.3)

(183.2)

(238.5)

(408.6)

Financing activities

Shares issued

1.4

-

7.1

24.1

Shares redeemed

(164.7)

(277.9)

(696.5)

(790.0)

Acquisition of treasury shares (note 10)

-

-

(5.8)

(11.3)

Increase in debt (note 9)

1.2

124.8

594.8

707.9

Repayment of debt (note 9)

(5.3)

(13.9)

(367.5)

(431.4)

Interest paid on debt

(20.5)

(17.4)

(134.9)

(126.5)

Payment of lease liabilities (principal)

(44.4)

(50.9)

(285.4)

(281.7)

Payment of lease liabilities (interest)

(10.8)

(9.0)

(56.2)

(52.7)

Dividends

(84.8)

(79.9)

(335.7)

(316.8)

(327.9)

(324.2)

(1,280.1)

(1,278.4)

Net change in cash and cash equivalents

60.2

(8.3)

42.8

37.9

Cash and cash equivalents - beginning of period

49.9

75.6

67.3

29.4

Cash and cash equivalents - end of period

110.1

67.3

110.1

67.3

See accompanying notes

  1. STATEMENT PRESENTATION‌‌‌

    METRO INC. (the Corporation) is incorporated under the laws of Québec. The Corporation is one of Canada's leading food and pharmacy retailers and distributors. It operates a network of supermarkets, discount stores and drugstores. Its head office is located at 11011 Maurice-Duplessis Blvd., Montréal, Québec, Canada, H1C 1V6. Its business segments, food operations and pharmaceutical operations, are combined into a single reportable operating segment due to the similar nature of their operations.

    The unaudited interim condensed consolidated financial statements for the 12-week period and fiscal year ended September 26, 2026 have been prepared by management in accordance with IAS 34 Interim Financial Reporting and using the same accounting policies and methods of computation as those used in preparing the audited annual consolidated financial statements for the year ended September 27, 2025. They should be read in conjunction with the audited annual consolidated financial statements and accompanying notes which were presented in the Corporation's 2025 Annual Report.

  2. NEW ACCOUNTING STANDARD‌ ACCOUNTING STANDARD ISSUED BUT NOT YET EFFECTIVE

    Presentation and Disclosures in Financial Statements

    In April 2024, the IASB issued IFRS 18, which replaces IAS 1 Presentation of Financial Statements, and consequential amendments to several other standards. IFRS 18 introduces new requirements for presentation within the statement of profit or loss, including specified totals and subtotals. Entities are required to classify all income and expenses within the statement of profit or loss into one of five categories: operating, investing, financing, income taxes and discontinued operations, with prescribed subtotals for each new category. It also requires disclosure of management-defined performance measures which will now form part of the audited financial statements.

    IFRS 18, and the amendments to the other standards, is effective for reporting periods beginning on or after January 1, 2027, but earlier application is permitted and must be disclosed. IFRS 18 will apply retrospectively. The Corporation is currently working to identify all impacts the amendments will have on the consolidated financial statements and notes to the consolidated financial statements.

  3. SALES‌

    The following table disaggregates the Corporation's sales based upon where the ultimate sales to consumers occur in our network of stores:

    12 weeks 52 weeks

    Fiscal Year Fiscal Year

    2026

    2025

    2026

    2025

    Food

    3,971.3

    3,986.7

    17,399.1

    17,127.0

    Pharmacy

    1,208.2

    1,122.0

    5,149.6

    4,879.7

    5,179.5

    5,108.7

    22,548.7

    22,006.7

  4. RESTRUCTURING EXPENSES AND IMPAIRMENT OF ASSETS‌

    As part of our continued efforts to address our customers' ongoing search for value and to strengthen our competitive position in targeted markets, we are proceeding with a reorganization of our Ontario store and distribution network which will result in the conversion of 10 Metro stores to the Food Basics discount banner, the closure of one store and the closure of a satellite warehouse. In addition, we will close our dedicated e-commerce fulfillment centre in Montreal and leverage our store network for the expansion of our delivery offering while reducing our cost structure.

    As a result of these initiatives, the Corporation recognized impairment of assets of $32.1 and restructuring expenses of $25.7 during the third quarter of Fiscal 2026. The impairment of assets related primarily to property and equipment, right-of-use assets, and leasehold improvements affected by the decision. The restructuring expenses consisted primarily of employee termination benefits, restoration and site closure costs, and lease-related costs associated with vacated facilities.

    The Corporation recognized impairment of assets of $1.8 during the fourth quarter of Fiscal 2026 regarding retail operations of Première Moisson Group Inc. The impairment of assets related primarily to property and equipment, right-of-use assets, and leasehold improvements.

  5. DISPOSAL OF COMMERCIAL BAKERY OPERATIONS‌

    On August 30, 2026, the Corporation's subsidiary, Première Moisson Group Inc., completed the sale to FGF Brands of its commercial bakery manufacturing operations located in Baie-D'Urfé and certain related assets and operations. The transaction represented the disposal of a business for accounting purposes. The Corporation retained ownership of the Première Moisson brand, its retail bakery network and its French pastry production operations located in Vaudreuil-Dorion.

    Total cash consideration was $90.0, including $75.0 attributable to the disposed business and $15.0 related to a five-year product supply agreement. The $15.0 was accounted for separately from the disposal and was not included in the consideration used to determine the gain on disposal. It was recognized as deferred income and will be amortized to earnings on a straight-line basis over the five-year contractual term of the agreement. The consideration used to determine the gain was $75.0.

    The disposed operations did not represent a separate major line of business or a major geographical area of operations and, accordingly, the transaction was not presented as a discontinued operation.

    Net assets disposed of

    Closing net working capital adjustment

    9.7

    Property, plant and equipment

    28.4

    Goodwill

    18.1

    56.2

    Gain on disposal

    Cash consideration attributable to the disposed business

    75.0

    Less: net assets disposed of

    (56.2)

    Less: transaction costs and closing net working capital adjustment

    (4.1)

    Gain on disposal before income taxes

    14.7

    The gain on disposal was recognized in operating income in the consolidated statements of net income. Net cash proceeds of $70.9, representing the $75.0 of cash consideration attributable to the disposed business, less transaction costs and closing adjustments of $4.1, were presented within investing activities in the consolidated statements of cash flows.

  6. INVENTORIES WRITE-DOWN‌

    The Corporation recognized an expense of $24.5 for the write-down to net realizable value of inventories during the 12-week period and fiscal year ended September 27, 2025.

    This write-down relates to frozen product inventories that were deemed unsalvageable following a mechanical failure of the refrigeration system at the frozen food distribution centre in Toronto. The operations at the distribution centre were interrupted on September 12, 2025, and resumed during the first quarter of 2026.

    The Corporation also incurred $6.1 in other direct costs, primarily for specialized equipment rental and transportation, which were included in operating expenses.

  7. INCOME TAXES‌

    The effective income tax rates were as follows:

    12 weeks

    52 weeks

    Fiscal Year

    Fiscal Year

    (Percentage)

    2026

    2025

    2026

    2025

    Combined statutory income tax rate

    26.5

    26.5

    26.5

    26.5

    Changes

    Favourable adjustments resulting from a tax holiday on a large

    investment project

    (2.8)

    (1.0)

    (2.0)

    (1.7)

    Tax adjustments in respect of prior years

    1.2

    (1.4)

    0.3

    (2.1)

    Other

    0.2

    -

    -

    0.1

    25.1

    24.1

    24.8

    22.8

  8. NET EARNINGS PER SHARE‌

    Basic net earnings per share and fully diluted net earnings per share were calculated using the following number of shares:

    (Millions)

    12 weeks

    Fiscal Year

    2026

    2025

    52 weeks

    Fiscal Year

    2026

    2025

    Weighted average number of shares outstanding - Basic Dilutive effect under:

    208.3

    216.2

    211.0

    218.9

    Stock option plan

    0.4

    0.5

    0.4

    0.5

    Performance share unit plan

    0.3

    0.3

    0.3

    0.3

    Weighted average number of shares outstanding - Fully diluted

    209.0

    217.0

    211.7

    219.7

  9. DEBT‌

    On February 25, 2026, the Corporation issued through a private placement Series M unsecured senior notes in the aggregate principal amount of $350.0, bearing interest at a fixed nominal rate of 3.469%, maturing on February 25, 2031.

    On December 2, 2024, the Corporation redeemed all of the Series J notes, bearing interest at a fixed nominal rate of 1.92%, in the amount of $300.0 that matured on the same day.

    On November 27, 2024, the Corporation issued through a private placement Series L unsecured senior notes in the aggregate principal amount of $500.0, bearing interest at a fixed nominal rate of 3.998%, maturing on November 27, 2029. In anticipation of this issuance, on November 22, 2024, the Corporation entered into a bond forward contract designated as a cash flow hedge on a portion of a highly probable future debt issuance in the amount of $100.0 that effectively locked in a 5-year fixed underlying Government of Canada yield of 3.351%. The effective part of the loss on the hedging instrument was recognized in Other Comprehensive Income. Following the Series L notes issuance, the amounts accumulated in equity will be reclassified to net financial costs on a linear basis over the life of the debt.

  10. CAPITAL STOCK‌ COMMON SHARES ISSUED

    The common shares issued and the changes during the fiscal year ended September 26, 2026 were summarized as follows:

    Number

    (Thousands)

    Balance as at September 28, 2024

    222,702

    1,575.5

    Shares redeemed for cash, excluding premium of $731.8

    (8,154)

    (58.2)

    Stock options exercised

    499

    27.4

    Balance as at September 27, 2025

    215,047

    1,544.7

    Shares redeemed for cash, excluding premium of $642.9

    (7,444)

    (53.6)

    Stock options exercised

    125

    8.1

    Balance as at September 26, 2026

    207,728

    1,499.2

    TREASURY SHARES

    The changes in treasury shares during the fiscal year ended September 26, 2026 were summarized as follows:

    Number

    (Thousands)

    Balance as at September 28, 2024

    288

    (19.6)

    Acquisition

    110

    (11.3)

    Release

    (99)

    5.8

    Balance as at September 27, 2025

    299

    (25.1)

    Acquisition

    60

    (5.8)

    Release

    (96)

    7.2

    Balance as at September 26, 2026

    263

    (23.7)

    Treasury shares are held in trust for the performance share unit (PSU) plan. They will be released into circulation when the PSUs settle. The trust, considered a structured entity, is consolidated in the Corporation's financial statements.

    Excluding treasury shares from the common shares issued, the Corporation had 207,465,000 outstanding Common Shares issued as at September 26, 2026 (214,748,000 as at September 27, 2025).

    STOCK OPTION PLAN

    The outstanding options and the changes during the fiscal year ended September 26, 2026 were summarized as follows:

    Weighted average

    Number

    exercise price

    (Thousands)

    (Dollars)

    Balance as at September 28, 2024

    2,179

    61.15

    Granted

    330

    93.66

    Exercised

    (499)

    48.35

    Cancelled

    (41)

    70.55

    Balance as at September 27, 2025

    1,969

    69.65

    Granted

    238

    99.80

    Exercised

    (125)

    57.29

    Cancelled

    (31)

    79.38

    Balance as at September 26, 2026

    2,051

    73.75

    The exercise prices of the outstanding options ranged from $55.94 to $102.08 as at September 26, 2026 with expiration dates up to 2032. Of these options, 777,930 could be exercised at a weighted average exercise price of

    $62.43.

    The compensation expense for these options amounted to $1.1 and $4.2 for the 12-week period and fiscal year ended September 26, 2026 ($0.9 and $4.0 in 2025).

    PERFORMANCE SHARE UNIT PLAN

    PSUs outstanding and the changes during the fiscal year ended September 26, 2026 were summarized as follows:

    Number

    (Thousands)

    Balance as at September 28, 2024

    571

    Granted

    178

    Exercised

    (133)

    Cancelled

    (65)

    Balance as at September 27, 2025

    551

    Granted

    173

    Exercised

    (141)

    Cancelled

    (67)

    Balance as at September 26, 2026

    516

    The compensation expense for the PSU plan amounted to $2.3 and $10.1 for the 12-week period and fiscal year ended September 26, 2026 ($2.4 and $9.8 in 2025).

  11. CONTINGENCIES‌

    In the normal course of business, various proceedings and claims are instituted against the Corporation. The Corporation contests the validity of these claims and proceedings and at this stage, the Corporation does not believe that these matters will have a material effect on the Corporation's financial position or on consolidated earnings. However, since any litigation involves uncertainty, it is not possible to predict the outcome of these claims or the amount of potential losses. No accruals or provisions for contingent losses have been recognized in the Corporation's annual consolidated financial statements.

    In May 2019, two (2) proposed class actions relating to opioids were filed in Ontario and in Quebec by opioid end users against a large group of defendants including, in Quebec, a subsidiary of the Corporation, Pro Doc Ltée ("Pro Doc"), and, in Ontario, Pro Doc and The Jean Coutu Group (PJC) Inc. ("Jean Coutu Group"). In December 2023, the Ontario Superior Court of Justice dismissed the Ontario class action against Pro Doc, Jean Coutu Group and the distributor defendants. As plaintiff did not appeal the decision, this decision is therefore final. In April 2024, the Quebec Superior Court authorized the Québec class action, the authorization process being merely a procedural step and the judgment in no way decides the case on the merits. For the sole purpose of avoiding the costs and inconvenience of this class action, Pro Doc and its insurers have agreed to settle the Québec class action out of court, without any admission and while continuing to deny any allegation of fault or liability. The settlement agreement was approved by the Quebec Superior Court on December 22, 2025.

    In August 2018, the Province of British Columbia filed a proposed class action against numerous manufacturers and distributors of opioids, including subsidiaries of the Corporation, Pro Doc and Jean Coutu Group. The Province of British Columbia seeks damages (unquantified) on behalf of all federal, provincial and territorial governments and agencies for expenses allegedly incurred in paying for opioid prescriptions and other healthcare costs that would be related to opioid addiction and abuse. In January 2025, the Court certified the class action against all defendants, the certification process being merely a procedural step and the judgment in no way decides the case on the merits. That decision was confirmed by the Court of Appeal in June 2026. For the sole purpose of avoiding the costs and inconvenience of this class action, Pro Doc, Jean Coutu Group and their insurers have agreed to an out-of-court settlement, without any admission and while continuing to deny any allegation of fault or liability. The settlement agreement has been submitted to the Supreme Court of British Columbia for approval. The Corporation does not expect the settlement to have a material effect on its financial position, results of operations or cash flows.

    In February 2020, a proposed class action relating to opioids was filed in British Columbia by opioid end users against a large group of defendants including subsidiaries of the Corporation, Pro Doc and Jean Coutu Group. In April 2021, a proposed class action relating to opioids was filed in Alberta by the City of Grande Prairie (Alberta) and the City of Brantford (Ontario). That proposed class action, amended in late November 2024, is made against multiple defendants, including the Corporation, Pro Doc and Jean Coutu Group. In September 2021, a proposed class action relating to opioids was filed by the Peter Ballantyne Cree Nation and the Lac La Ronge Indian Band, in Saskatchewan. That proposed class action, amended in May 2026, was brought against multiple defendants, including the Corporation, Pro Doc and Jean Coutu Group. The allegations in these proposed class actions are similar to the allegations contained in the proposed class action filed by the Province of British Columbia in 2018. They include allegations of breach of the Competition Act, of fraudulent misrepresentation and deceit, and negligence. The City of Grande Prairie, on its behalf and on behalf of all Canadian municipalities and local governments, seeks damages which are unquantified in relation to public safety, social service, and criminal justice costs allegedly incurred due to the opioid crisis. The Peter Ballantyne Cree Nation and the Lac La Ronge Indian Band are attempting a similar recourse, claiming unquantified damages from multiple defendants on their own behalf and on behalf of all Indigenous, First Nations, Inuit and Metis communities and governments in Canada. The Corporation believes these proceedings are without merits and that, in certain cases, there is no jurisdiction. No provisions for contingent losses have been recognized in the Corporation's annual financial statements.

    In 2017, the Canadian Competition Bureau began an investigation into the supply and sale of commercial bread which involves certain Canadian suppliers and retailers, including the Corporation. Based on the information available to date, the Corporation does not believe that it or any of its employees have violated the Competition Act. Proposed class-action lawsuits have also been filed against the Corporation, suppliers and other retailers. On December 19, 2019, the Quebec Superior Court granted the application for authorization to institute one of these class actions, the authorization process being merely a procedural step and the judgment in no way decides the case on the merits. On December 31, 2021, the Ontario Superior Court of Justice partially certified another of these class actions. The

    Corporation is contesting all these actions at the certification stage and on the merits. No provisions for contingent losses have been recognized in the Corporation's annual consolidated financial statements.

    During the 2016 fiscal year, an application for authorization to institute a class action was served on Jean Coutu Group by Sopropharm, an association incorporated under the Professional Syndicates Act of which certain franchised drugstore owners of the Jean Coutu Group are members. The application seeks to have the class action authorized in the form of a declaratory action seeking amongst others (i) to set aside certain contractual provisions of the Jean Coutu Group's standard franchise agreements, including the clause providing for the payment of royalties on sales of medication by franchised establishments; (ii) to restore certain benefits; and (iii) to reduce certain contractual obligations. On November 1, 2018, the Quebec Superior Court granted the application for authorization to institute a class action, the authorization process being merely a procedural step and the judgment in no way decides the case on the merits. The Corporation contests this action on the merits. No provisions for contingent losses have been recognized in the Corporation's annual consolidated financial statements.

  12. FINANCIAL INSTRUMENTS‌

    The book and fair values of financial instruments, other than those with carrying amounts which were a reasonable approximation of their fair values, were as follows:

    As at September 26, 2026 As at September 27, 2025

    Book value Fair value Book value Fair value

    Other assets

    Assets measured at amortized cost

    Loans to certain customers 50.0 50.0 44.3 44.3

    Debt

    Liabilities measured at amortized cost

    Revolving Credit Facility

    -

    -

    118.0

    118.0

    Series G Notes

    450.0

    449.2

    450.0

    457.9

    Series L Notes (note 9)

    500.0

    497.5

    500.0

    519.5

    Series M Notes (note 9)

    350.0

    338.4

    -

    -

    Series K Notes

    300.0

    302.1

    300.0

    316.6

    Series B Notes

    400.0

    431.9

    400.0

    467.3

    Series D Notes

    300.0

    284.3

    300.0

    306.0

    Series H Notes

    450.0

    380.8

    450.0

    411.8

    Series I Notes

    400.0

    289.6

    400.0

    311.7

    Loans, net of deferred financing costs

    36.7

    36.7

    37.3

    37.3

    3,186.7

    3,010.5

    2,955.3

    2,946.1

    The fair value of loans to certain customers and loans payable are equivalent to their carrying values since their interest rates are comparable to market rates. The Corporation categorized the fair value measurement in Level 2, as it is derived from observable market inputs.

    The fair value of notes represents the obligations that the Corporation would have to meet in the event of the negotiation of similar notes under current market conditions. The Corporation categorized the fair value measurement in Level 2, as it is derived from observable market inputs.

  13. CHANGES IN DEFINED BENEFIT PLANS‌

    During the 12-week period ended September 26, 2026, the Corporation recognized actuarial losses of $15.4 in the consolidated statements of comprehensive income, mainly attributable to an unfavorable change in the fair value of plan assets, partially offset by a decrease in the obligation resulting from an increase in the discount rate from 5.12% on July 4, 2026, to 5.51% as at September 26, 2026. For the fiscal year ended September 26, 2026, the Corporation recognized actuarial gains of $37.4 in the consolidated statements of comprehensive income, mainly attributable to a decrease in the obligation resulting from an increase in the discount rate from 5.04% as at September 27, 2025 to 5.51% as at September 26, 2026, partly offset by an unfavourable change in the fair value of plan assets.

    During the 12-week period and fiscal year ended September 27, 2025, the Corporation recorded, in the consolidated statements of comprehensive income, actuarial gains of $58.6 and $128.3 respectively, attributable to the variation in the fair value of plan assets and to the variation in discount rates from 4.75% as at September 28, 2024 to 5.04% as at September 27, 2025.

    Post-employment benefits expense recorded in the consolidated statements of income during the 12-week period and fiscal year ending September 26, 2026 was $15.1 and $70.2 ($16.9 and $80.5 in 2025).

    On February 6, 2025, the Corporation entered into annuity buy-out contracts with a Canadian insurance company for six of its seven defined benefit pension plans. These contracts eliminated all further legal or constructive obligations to the Corporation for payments due after June 30, 2025 in respect of 519 annuities in payment. All six plans remain open. The pension plans paid a total premium of $127.6 to transfer and settle $128.9 of pension benefit obligations. Accordingly, the Corporation derecognized the buy-out annuity assets and defined benefit obligations previously recognized on a net basis. The transactions resulted in a net settlement gain of $1.3 in total for the six plans, which was recognized in the consolidated statements of net income.

  14. COMPARATIVE FIGURES‌

    Certain amounts previously presented within accounts receivable are now presented within prepaid expenses to conform with the presentation adopted in the current year. These reclassifications had no impact on previously reported net earnings, equity or cash flows.

  15. APPROVAL OF FINANCIAL STATEMENTS

The interim condensed consolidated financial statements for the 12-week period and fiscal year ended September 26, 2026 (including comparative figures) were approved for issue by the Board of Directors on November 17, 2026.

‌INFORMATION

METRO INC.'s Investor Relations Department Telephone: (514) 643-1000

METRO INC.'s corporate information and press releases are available on our website: https://www.corpo.metro.ca

Metro Inc. on 6ix

Story so far

Earlier from Metro

All Metro news releases